[{"indications": "Indications\u00a0(specialist use only) improvement of\r\nwalking disability in multiple sclerosis", "name": "FAMPRIDINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "10 Musculoskeletal and joint diseases", "10.2 Drugs used in neuromuscular disorders", "10.2.1 Drugs that enhance neuromuscular transmission", "Acetylcholine-release enhancers", "FAMPRIDINE"], "cautions": "Cautions\u00a0predisposition to seizures including concomitant use\r\nof drugs that lower seizure threshold; symptomatic cardiac rhythm\r\ndisorders, sinoatrial or atrioventricular conduction\r\ndisorders;interactions: Appendix 1 (fampridine)", "side-effects": "Side-effects\u00a0nausea, vomiting, constipation, dyspepsia, dyspnoea,\r\npharyngolaryngeal pain, dizziness, headache, paraesthesia, tremor,\r\nmalaise, insomnia, anxiety, urinary tract infection, back pain; less commonly seizures", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/218785.htm", "doses": ["adult over 18 years, 10\u00a0mg\r\nevery 12 hours; discontinue treatment if no improvement within 2 weeks"], "pregnancy": "Pregnancy\u00a0avoid\u2014toxicity in animal studies"}]